With reference to the ‘FAITH’ trials, consider the following statements:
1. Glenmark Pharmaceuticals Ltd. will conduct ‘FAITH’ trials to test combined efficacy of two antiviral drugs — Favipiravir and Umifenovxir — as potential COVID-19 treatment strategy.
2. The two antiviral drugs combination may demonstrate improved treatment efficacy by effectively tackling high viral loads in patients during early stages of the disease.
Which of the statements given above is/are correct?